Search
for
Sort by
Research 691–720 of 1000+
- Cosmetic Approach for Men
- Referee report. For: Treatment of chronic telogen effluvium with oral minoxidil: A retrospective study [version 1; referees: 2 approved]
- Cutaneous and Oral Mucosal Lesions in Cri-du-chat Syndrome
- Polycystic Ovary Syndrome: Conditions, Genetics and Current Cure
- The skin findings of pregnant women and our treatment choices. A Turkish experience: a 5-year survey.
- Alopecia: managing the basics
- Системная терапия больных андрогенетической алопецией
- Diabetes, ovarian tumor, hyperparathyroidism, and papillary cancer: A chance association?
- B‐ RAF , naevi and melanoma: a complex relationship
- Alopecia and drugs
- Nails and hair
- Pituitary-dependent hyperadrenocorticism in a shi tzu dog treated with twice-daily oral trilostane: a case report
- Oral Presentations
- Medical Management Options for Hair Loss
- Polycystic Ovarian Syndrome: The Androgenized Adolescent
- Dermatological drugs, topical agents, and cosmetics
- Edema periorbitario matutino por minoxidil oral a dosis bajas
- A systematic review of clinical trials using single or combination therapy of oral or topical finasteride for women in reproductive age and postmenopausal women with hormonal and nonhormonal androgenetic alopecia
- The Efficacy and Safety of Oral and Topical Spironolactone in Androgenetic Alopecia Treatment: A Systematic Review
- Oral Administration of TrkB Agonist, 7, 8–Dihydroxyflavone Regenerates Hair Cells and Restores Function after Gentamicin–Induced Vestibular Injury in Guinea Pig
- Efficacy and Tolerability of a Topical Gel Containing Mimicking Growth Factors Oligopeptides, Caffeine, Taurine and an Iron-Chelating Complex in Subjects with Androgenetic Alopecia Treated with Topical Minoxidil or Oral Finasteride: a Prospective, 6-Month, Randomized, Assessor-Blinded, 4-Arm, Parallel Group Study
- Edema periorbitario matutino por minoxidil oral a dosis bajas
- Role of oral minoxidil in patterned hair loss
- Analysis of Female Pattern Hair loss
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
- Efficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb/III and long-term phase III clinical studies in alopecia areata
- First-in-Man Clinical Trial of the Oral Pan-AKT Inhibitor MK-2206 in Patients With Advanced Solid Tumors
- Rapid skin repigmentation on oral ruxolitinib in a patient with coexistent vitiligo and alopecia areata (AA)
- From Diospyros kaki L. (Persimmon) Phytochemical Profile and Health Impact to New Product Perspectives and Waste Valorization
- Teriflunomide: A Once-daily Oral Medication for the Treatment of Relapsing Forms of Multiple Sclerosis